help button home button Am J Pathol ASIP MEMBERSHIP
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fukumoto, H.
Right arrow Articles by Iwatsubo, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fukumoto, H.
Right arrow Articles by Iwatsubo, T.

American Journal of Pathology, Vol 148, 259-265, Copyright © 1996 by American Society for Investigative Pathology


REGULAR ARTICLES

Amyloid beta protein deposition in normal aging has the same characteristics as that in Alzheimer's disease. Predominance of A beta 42(43) and association of A beta 40 with cored plaques

H Fukumoto, A Asami-Odaka, N Suzuki, H Shimada, Y Ihara and T Iwatsubo
Department of Neuropathology and Neuroscience Faculty of Pharmaceutical Sciences, University of Tokyo, Japan.

Two distinct species of amyloid beta protein (A beta) with different C- termini, A beta 42(43) and A beta 40, are deposited in senile plaques (SP) of Alzheimer's disease (AD), with the former being far predominant. To investigate whether A beta 42(43) also predominates over A beta 40 in normal aging, we examined by immunocytochemistry the C-termini of A beta in SP in the brains of non-demented aged individuals and compared the results with those in AD. Virtually all SP were A beta 42(43)-positive; of these 12% in non-demented aged individuals and 25% in AD patients (mean of three areas examined) were also A beta 40-positive. In both the AD and non-demented groups, 2/3 of the A beta 40-positive SP were typical cored SP. These results indicate that A beta 42(43) is the predominant species deposited in SP in normal aging, and there is no qualitative difference in terms of the C- terminus of A beta in the parenchymal amyloid deposition between normal aging and AD.


This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
H. Fukumoto, D. L. Rosene, M. B. Moss, S. Raju, B. T. Hyman, and M. C. Irizarry
{beta}-Secretase Activity Increases with Aging in Human, Monkey, and Mouse Brain
Am. J. Pathol., February 1, 2004; 164(2): 719 - 725.
[Abstract] [Full Text] [PDF]


Home page
Arch NeurolHome page
S. Parvathy, P. Davies, V. Haroutunian, D. P. Purohit, K. L. Davis, R. C. Mohs, H. Park, T. M. Moran, J. Y. Chan, and J. D. Buxbaum
Correlation Between A{beta}x-40-, A{beta}x-42-, and A{beta}x-43-Containing Amyloid Plaques and Cognitive Decline
Arch Neurol, December 1, 2001; 58(12): 2025 - 2031.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Takeuchi, M. C. Irizarry, K. Duff, T. C. Saido, K. Hsiao Ashe, M. Hasegawa, D. M. A. Mann, B. T. Hyman, and T. Iwatsubo
Age-Related Amyloid {beta} Deposition in Transgenic Mice Overexpressing Both Alzheimer Mutant Presenilin 1 and Amyloid {beta} Precursor Protein Swedish Mutant Is Not Associated with Global Neuronal Loss
Am. J. Pathol., July 1, 2000; 157(1): 331 - 339.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
D. G. Munoz and H. Feldman
Causes of Alzheimer's disease
Can. Med. Assoc. J., January 1, 2000; 162(1): 65 - 72.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
A. Kato, A. Fukunari, Y. Sakai, and T. Nakajima
Prevention of Amyloid-Like Deposition by a Selective Prolyl Endopeptidase Inhibitor, Y-29794, in Senescence-Accelerated Mouse
J. Pharmacol. Exp. Ther., October 1, 1997; 283(1): 328 - 335.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
E. M. Castano, F. Prelli, C. Soto, R. Beavis, E. Matsubara, M. Shoji, and B. Frangione
The length of Amyloid-beta in Hereditary Cerebral Hemorrhage with Amyloidosis, Dutch Type. IMPLICATIONS FOR THE ROLE OF AMYLOID-beta 1-42 IN ALZHEIMER'S DISEASE
J. Biol. Chem., December 13, 1996; 271(50): 32185 - 32191.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. McLaurin and A. Chakrabartty
Membrane Disruption by Alzheimer beta -Amyloid Peptides Mediated through Specific Binding to Either Phospholipids or Gangliosides. IMPLICATIONS FOR NEUROTOXICITY
J. Biol. Chem., October 25, 1996; 271(43): 26482 - 26489.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1996 by the American Society for Investigative Pathology.